Overview
Jie-qin Wang practices practicing medicine in Guangzhou, China.
Wang is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, and Cholangiocarcinoma (Bile Duct Cancer).
They are actively involved in clinical research, co-authoring 11 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jie-qin Wang
Is Jie-qin Wang a top-rated expert for Pancreatic Ductal Adenocarcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Jie-qin Wang is classified as an Advanced expert for Pancreatic Ductal Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jie-qin Wang participate in research or clinical trials?
Yes. Jie-qin Wang has published 11 articles and abstracts on conditions like Pancreatic Ductal Adenocarcinoma. You can view a list of Jie-qin Wang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Pancreatic Ductal Adenocarcinoma
- Experienced
- Cholangiocarcinoma (Bile Duct Cancer)
- Pancreatic CancerWang isExperienced. Learn about Pancreatic Cancer.